vtioВестник трансплантологии и искусственных органовRussian Journal of Transplantology and Artificial Organs1995-1191Academician V.I.Shumakov National Medical Research Center of Transplantology and Artificial Organs", Ministry of Health of the Russian Federation10.15825/1995-1191-2024-2-51-57vtio-1770Research ArticleТрансплантация сердца и вспомогательное кровообращениеHeart Transplantation and Assisted CirculationОптимальные стратегии профилактики ишемического реперфузионного повреждения при трансплантации сердца с длительной холодовой ишемией трансплантата (обзор)Optimal strategies for prevention of ischemia‑reperfusion injury in heart transplantation with prolonged cold ischemia time (review)ФомичевА. В.FomichevA. V.

Новосибирск

Novosibirsk

a_fomichev@meshalkin.ruГармаевГ. Б.GarmaevG. B.

Новосибирск

Novosibirsk

garmaev_g@meshalkin.ruЖульковМ. О.ZhulkovM. O.

Новосибирск

Novosibirsk

medicus-maligna@mail.ruЗыковИ. С.ZykovI. S.

Новосибирск

Novosibirsk

i_zykov@meshalkin.ruМакаевА. Г.MakaevA. G.

Новосибирск

Novosibirsk

makaev_a@meshalkin.ruПротопоповА. В.ProtopopovA. V.

Протопопов Андрей Владимирович

630055, Новосибирск, ул. Речкуновская, д. 15.

Тел. (914) 708-39-79

Andrey Protopopov

15, Rechkunovskaya str., 630055, Novosibirsk

Phone: (914) 708-39-79

andrew-uss@yandex.ruТарковаА. Р.TarkovaA. R.

Новосибирск

Novosibirsk

a_tarkova@meshalkin.ruМуртазалиевМ. Н.MurtazalievM. N.

Новосибирск

Novosibirsk

murtazaliev_m@meshalkin.ruСмирновЯ. М.SmirnovYa. M.

Новосибирск

Novosibirsk

y.smirnov@g.nsu.ruЛиманскийА. Д.LimanskiyA. D.

Новосибирск

Novosibirsk

a.limanskii@g.nsu.ruГусеваА. В.GusevaA V.

Новосибирск

Novosibirsk

gusevaanastasya@mail.ruКалдарК. Н.KaldarK. N.

Новосибирск

Novosibirsk

kaisarkaldar@mail.ruСиротаД. А.SirotaD. A.

Новосибирск

Novosibirsk

d_sirota@meshalkin.ruФГБУ «Национальный медицинский исследовательский центр имени академика Е.Н. Мешалкина» Минздрава РоссииРоссияMeshalkin National Medical Research CenterRussian FederationФГБУ «Национальный медицинский исследовательский центр имени академика Е.Н. Мешалкина» Минздрава России; ФГБОУ ВО «Новосибирский государственный медицинский университет» Минздрава РоссииРоссияMeshalkin National Medical Research Center; Novosibirsk State Medical UniversityRussian Federation2024080420242625157Copyright © Фомичев А.В., Гармаев Г.Б., Жульков М.О., Зыков И.С., Макаев А.Г., Протопопов А.В., Таркова А.Р., Муртазалиев М.Н., Смирнов Я.М., Лиманский А.Д., Гусева А.В., Калдар К.Н., Сирота Д.А., 20242024Фомичев А.В., Гармаев Г.Б., Жульков М.О., Зыков И.С., Макаев А.Г., Протопопов А.В., Таркова А.Р., Муртазалиев М.Н., Смирнов Я.М., Лиманский А.Д., Гусева А.В., Калдар К.Н., Сирота Д.А.Fomichev A.V., Garmaev G.B., Zhulkov M.O., Zykov I.S., Makaev A.G., Protopopov A.V., Tarkova A.R., Murtazaliev M.N., Smirnov Y.M., Limanskiy A.D., Guseva A.V., Kaldar K.N., Sirota D.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.transpl.ru/vtio/article/view/1770

На сегодняшний день проблема недостатка донорских органов остается одной из главных в трансплантологии. Транспортировка донорских органов на значительные расстояния ведет к увеличению времени холодовой ишемии, что повышает риск ишемически-реперфузионных повреждений. Метод и время консервации играют ключевую роль для увеличения пула доноров в условиях критического дефицита. В данной работе проанализирован международный опыт подхода к способам консервации донорских органов, их преимущества и недостатки.

The shortage of organs for transplant remains a major challenge in transplantology. Transporting donor organs over long distances increases cold ischemia time, which is a risk factor for ischemia-reperfusion injury (IRI). In the face of critical shortages, the method and timing of organ preservation are crucial in increasing the donor pool. This paper examines the approaches, benefits, and drawbacks of organ preservation techniques used around the world.

кардиоплегияишемически-реперфузионное повреждениетрансплантация сердцааллографтcardioplegiaischemia-reperfusion injuryheart transplantationallograftРабота выполнена при поддержке гранта Российского научного фонда (проект 24-25-00352).ReferencesФомичев АВ, Попцов ВН, Сирота ДА, Жульков МО, Едемский АГ, Протопопов АВ и др. Среднесрочные и отдаленные результаты трансплантации серд ца с длительной холодовой ишемией. Вестник трансплантологии и искусственных органов. 2023; 25 (1): 99–105. https://doi.org/10.15825/1995-1191-2023-1-99-105.Fomichev AV, Poptsov VN, Sirota DA, Zhulkov MO, Edemskiy AG, Protopopov АV et al. Mid-term and long-term outcomes following heart transplantation with prolonged cold ischemia. Russian Journal of Transplantology and Artificial Organs. 2023; 25 (1): 99–105. https://doi.org/10.15825/1995-1191-2023-1-99-105.Erasmus M, Neyrink A, Sabatino M, Potena L. Heart allograft preservation: an arduous journey from the donor to the recipient. Curr Opin Cardiol. 2017; 32 (3): 292– 300. https://doi.org/10.1097/hco.0000000000000395.Erasmus M, Neyrink A, Sabatino M, Potena L. Heart allograft preservation: an arduous journey from the donor to the recipient. Curr Opin Cardiol. 2017; 32 (3): 292– 300. https://doi.org/10.1097/hco.0000000000000395.Segovia J, Cosío MD, Barceló JM, Bueno MG, Pavía PG, Burgos R et al. RADIAL: a novel primary graft failure risk score in heart transplantation. J Heart Lung Transplant. 2011; 30 (6): 644–651. https://doi.org/10.1016/j.healun.2011.01.721.Segovia J, Cosío MD, Barceló JM, Bueno MG, Pavía PG, Burgos R et al. RADIAL: a novel primary graft failure risk score in heart transplantation. J Heart Lung Transplant. 2011; 30 (6): 644–651. https://doi.org/10.1016/j.healun.2011.01.721.Lund LH, Khush KK, Cherikh WS, Goldfarb S, Kucheryavaya AY, Levvey BJ et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Heart Transplantation Report – 2017; Focus Theme: Allograft ischemic time. J Heart Lung Transplant. 2017; 36 (10): 1037–1046. https://doi.org/10.1016/j.healun.2017.07.019.Lund LH, Khush KK, Cherikh WS, Goldfarb S, Kucheryavaya AY, Levvey BJ et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Heart Transplantation Report – 2017; Focus Theme: Allograft ischemic time. J Heart Lung Transplant. 2017; 36 (10): 1037–1046. https://doi.org/10.1016/j.healun.2017.07.019.Redd MA, Scheuer SE, Saez NJ, Yoshikawa Y, Chiu HS, Gao L et al. Therapeutic Inhibition of Acid-Sensing Ion Channel 1a Recovers Heart Function After Ischemia-Reperfusion Injury. Circulation. 2021; 144 (12): 947–960. https://doi.org/10.1161/cir.0000000000001020.Redd MA, Scheuer SE, Saez NJ, Yoshikawa Y, Chiu HS, Gao L et al. Therapeutic Inhibition of Acid-Sensing Ion Channel 1a Recovers Heart Function After Ischemia-Reperfusion Injury. Circulation. 2021; 144 (12): 947–960. https://doi.org/10.1161/cir.0000000000001020.Minasian SM, Galagudza MM, Dmitriev YV, Karpov AA, Vlasov TD. Preservation of the donor heart: from basic science to clinical studies. Interact Cardiovasc Thorac Surg. 2015; 20 (4): 510–519. https://doi.org/10.1093/icvts/ivu432.Minasian SM, Galagudza MM, Dmitriev YV, Karpov AA, Vlasov TD. Preservation of the donor heart: from basic science to clinical studies. Interact Cardiovasc Thorac Surg. 2015; 20 (4): 510–519. https://doi.org/10.1093/icvts/ivu432.Rauen U, Klempt S, De Groot H. Histidine-induced injury to cultured liver cells, effects of histidine derivatives and of iron chelators. Cell Mol Life Sci. 2007; 64 (2): 192–205. https://doi.org/10.1007/s00018-006-6456-1.Rauen U, Klempt S, De Groot H. Histidine-induced injury to cultured liver cells, effects of histidine derivatives and of iron chelators. Cell Mol Life Sci. 2007; 64 (2): 192–205. https://doi.org/10.1007/s00018-006-6456-1.Kim ST, Helmers MR, Iyengar A, Han JJ, Patrick WL, Weingarten N D et al. Interaction between donor obesity and prolonged donor ischemic time in heart transplantation. J Cardiol. 2022; 80 (4): 351–357. https://doi.org/10.1016/j.jjcc.2022.06.013.Kim ST, Helmers MR, Iyengar A, Han JJ, Patrick WL, Weingarten N D et al. Interaction between donor obesity and prolonged donor ischemic time in heart transplantation. J Cardiol. 2022; 80 (4): 351–357. https://doi.org/10.1016/j.jjcc.2022.06.013.Ribeiro RVP, Friedrich JO, Ouzounian M, Yau T, Lee J, Yanagawa B. Supplemental Cardioplegia During Donor Heart Implantation: A Systematic Review and MetaAnalysis. Ann Thorac Surg. 2020; 110 (2): 545–552. https://doi.org/10.1016/j.athoracsur.2019.10.094.Ribeiro RVP, Friedrich JO, Ouzounian M, Yau T, Lee J, Yanagawa B. Supplemental Cardioplegia During Donor Heart Implantation: A Systematic Review and MetaAnalysis. Ann Thorac Surg. 2020; 110 (2): 545–552. https://doi.org/10.1016/j.athoracsur.2019.10.094.Luciani GB, Faggian G, Montalbano G, Casali G, Forni A, Chiominto B, Mazzucco A. Blood versus crystalloid cardioplegia for myocardial protection of donor hearts during transplantation: A prospective, randomized clinical trial. J Thorac Cardiovasc Surg. 1999; 118 (5): 787– 795. https://doi.org/10.1016/s0022-5223(99)70047-4.Luciani GB, Faggian G, Montalbano G, Casali G, Forni A, Chiominto B, Mazzucco A. Blood versus crystalloid cardioplegia for myocardial protection of donor hearts during transplantation: A prospective, randomized clinical trial. J Thorac Cardiovasc Surg. 1999; 118 (5): 787– 795. https://doi.org/10.1016/s0022-5223(99)70047-4.Luciani GB, Faggian G, Forni A, Montalbano G, Chiominto B, Mazzucco A. Myocardial protection during heart transplantation using blood cardioplegia. Transplant Proc. 1997; 29 (8): 3386–3388. https://doi.org/10.1016/s0041-1345(97)00950-0.Luciani GB, Faggian G, Forni A, Montalbano G, Chiominto B, Mazzucco A. Myocardial protection during heart transplantation using blood cardioplegia. Transplant Proc. 1997; 29 (8): 3386–3388. https://doi.org/10.1016/s0041-1345(97)00950-0.Luciani GB, Forni A, Rigatelli G, Chiominto B, Cardaioli P, Mazzucco A, Faggian G. Myocardial protection in heart transplantation using blood cardioplegia: 12year outcome of a prospective randomized trial. J Heart Lung Transplant. 2011; 30 (1): 29–36. https://doi.org/10.1016/j.healun.2010.08.014.Luciani GB, Forni A, Rigatelli G, Chiominto B, Cardaioli P, Mazzucco A, Faggian G. Myocardial protection in heart transplantation using blood cardioplegia: 12year outcome of a prospective randomized trial. J Heart Lung Transplant. 2011; 30 (1): 29–36. https://doi.org/10.1016/j.healun.2010.08.014.Soots G, Crepin F, Prat A, Gosselin B, Pol A, Moreau D, Devulder JP. Cold blood cardioplegia and warm cardioplegic reperfusion in heart transplantation. Eur J Cardiothorac Surg. 1991; 5 (8): 400–404. https://doi.org/10.1016/1010-7940(91)90183-k.Soots G, Crepin F, Prat A, Gosselin B, Pol A, Moreau D, Devulder JP. Cold blood cardioplegia and warm cardioplegic reperfusion in heart transplantation. Eur J Cardiothorac Surg. 1991; 5 (8): 400–404. https://doi.org/10.1016/1010-7940(91)90183-k.Carrier M, Leung TK, Solymoss BC, Cartier R, Leclerc Y, Pelletier LC. Clinical trial of retrograde warm blood reperfusion versus standard cold topical irrigation of transplanted hearts. Ann Thorac Surg. 1996; 61 (5): 1310– 1315. https://doi.org/10.1016/0003-4975(96)00075-6.Carrier M, Leung TK, Solymoss BC, Cartier R, Leclerc Y, Pelletier LC. Clinical trial of retrograde warm blood reperfusion versus standard cold topical irrigation of transplanted hearts. Ann Thorac Surg. 1996; 61 (5): 1310– 1315. https://doi.org/10.1016/0003-4975(96)00075-6.Fiocchi R, Vernocchi A, Mammana C, Iamele L, Gamba A. Continuous retrograde warm blood reperfusion reduces cardiac troponin I release after heart transplantation: a prospective randomized study. Transpl Int. 2000; 13 Suppl 1: S240–S244. https://doi.org/10.1111/j.1432-2277.2000.tb02027.x.Fiocchi R, Vernocchi A, Mammana C, Iamele L, Gamba A. Continuous retrograde warm blood reperfusion reduces cardiac troponin I release after heart transplantation: a prospective randomized study. Transpl Int. 2000; 13 Suppl 1: S240–S244. https://doi.org/10.1111/j.1432-2277.2000.tb02027.x.Pradas G, Cuenca J, Juffe A. Continuous warm reperfusion during heart transplantation. J Thorac Cardiovasc Surg. 1996; 111 (4): 784–790. https://doi.org/10.1016/s0022-5223(96)70338-0.Pradas G, Cuenca J, Juffe A. Continuous warm reperfusion during heart transplantation. J Thorac Cardiovasc Surg. 1996; 111 (4): 784–790. https://doi.org/10.1016/s0022-5223(96)70338-0.Tevaearai Stahel HT, Unger D, Schmidli J, Gahl B, Englberger L, Kadner A et al. Supplemental Cardioplegia Immediately before Graft Implantation may Improve Early Post-Transplantation Outcome. Front Surg. 2014; 1: 46. https://doi.org/10.3389/fsurg.2014.00046.Tevaearai Stahel HT, Unger D, Schmidli J, Gahl B, Englberger L, Kadner A et al. Supplemental Cardioplegia Immediately before Graft Implantation may Improve Early Post-Transplantation Outcome. Front Surg. 2014; 1: 46. https://doi.org/10.3389/fsurg.2014.00046.Mozaffari MS, Liu JY, Abebe W, Baban B. Mechanisms of load dependency of myocardial ischemia reperfusion injury. Am J Cardiovasc Dis. 2013; 3 (4): 180–196.Mozaffari MS, Liu JY, Abebe W, Baban B. Mechanisms of load dependency of myocardial ischemia reperfusion injury. Am J Cardiovasc Dis. 2013; 3 (4): 180–196.Landymore RW, Bayes AJ, Murphy JT, Fris JH. Preconditioning prevents myocardial stunning after cardiac transplantation. Ann Thorac Surg. 1998; 66 (6): 1953– 1957. https://doi.org/10.1016/s0003-4975(98)00902-3.Landymore RW, Bayes AJ, Murphy JT, Fris JH. Preconditioning prevents myocardial stunning after cardiac transplantation. Ann Thorac Surg. 1998; 66 (6): 1953– 1957. https://doi.org/10.1016/s0003-4975(98)00902-3.Wang G, Zhang Y, Yang L, Chen Y, Fang Z, Zhou H et al. Cardioprotective effect of remote ischemic preconditioning with postconditioning on donor hearts in patients undergoing heart transplantation: A single-center, double-blind, randomized controlled trial. BMC Anesthesiol. 2019; 19 (1): 1–8. https://doi.org/10.21203/rs.2.182/v1.Wang G, Zhang Y, Yang L, Chen Y, Fang Z, Zhou H et al. Cardioprotective effect of remote ischemic preconditioning with postconditioning on donor hearts in patients undergoing heart transplantation: A single-center, double-blind, randomized controlled trial. BMC Anesthesiol. 2019; 19 (1): 1–8. https://doi.org/10.21203/rs.2.182/v1.Carter KT, Lirette ST, Baran DA, Creswell LL, Panos AL, Cochran RP et al. The Effect of Cardiac Preservation Solutions on Heart Transplant Survival. J Surg Res. 2019; 242: 157–165. https://doi.org/10.1016/j.jss.2019.04.041.Carter KT, Lirette ST, Baran DA, Creswell LL, Panos AL, Cochran RP et al. The Effect of Cardiac Preservation Solutions on Heart Transplant Survival. J Surg Res. 2019; 242: 157–165. https://doi.org/10.1016/j.jss.2019.04.041.George TJ, Arnaoutakis GJ, Beaty CA, Shah AS, Conte JV, Halushka MK. A novel method of measuring cardiac preservation injury demonstrates University of Wisconsin solution is associated with less ischemic necrosis than Celsior in early cardiac allograft biopsy specimens. J Heart Lung Transplant. 2012; 31 (4): 410–418. https://doi.org/10.1016/j.healun.2011.11.023.George TJ, Arnaoutakis GJ, Beaty CA, Shah AS, Conte JV, Halushka MK. A novel method of measuring cardiac preservation injury demonstrates University of Wisconsin solution is associated with less ischemic necrosis than Celsior in early cardiac allograft biopsy specimens. J Heart Lung Transplant. 2012; 31 (4): 410–418. https://doi.org/10.1016/j.healun.2011.11.023.Cannata A, Botta L, Colombo T, Russo CF, Taglieri C, Bruschi G et al. Does the cardioplegic solution have an effect on early outcomes following heart transplantation? Eur J Cardiothorac Surg. 2012; 41 (4): e48–e52. https://doi.org/10.1093/ejcts/ezr321.Cannata A, Botta L, Colombo T, Russo CF, Taglieri C, Bruschi G et al. Does the cardioplegic solution have an effect on early outcomes following heart transplantation? Eur J Cardiothorac Surg. 2012; 41 (4): e48–e52. https://doi.org/10.1093/ejcts/ezr321.Loganathan S, Radovits T, Hirschberg K, Korkmaz S, Koch A, Karck M, Szabó G. Effects of Custodiol-N, a novel organ preservation solution, on ischemia/reperfusion injury. J Thorac Cardiovasc Surg. 2010; 139 (4): 1048–1056. https://doi.org/10.1016/j.jtcvs.2009.09.034.Loganathan S, Radovits T, Hirschberg K, Korkmaz S, Koch A, Karck M, Szabó G. Effects of Custodiol-N, a novel organ preservation solution, on ischemia/reperfusion injury. J Thorac Cardiovasc Surg. 2010; 139 (4): 1048–1056. https://doi.org/10.1016/j.jtcvs.2009.09.034.Mohr A, Brockmann JG, Becker F. HTK-N: Modified Histidine-Tryptophan-Ketoglutarate Solution-A Promising New Tool in Solid Organ Preservation. Int J Mol Sci. 2020; 21 (18): 1–16. https://doi.org/10.3390/ijms21186468.Mohr A, Brockmann JG, Becker F. HTK-N: Modified Histidine-Tryptophan-Ketoglutarate Solution-A Promising New Tool in Solid Organ Preservation. Int J Mol Sci. 2020; 21 (18): 1–16. https://doi.org/10.3390/ijms21186468.Szabó G, Loganathan S, Korkmaz-Icöz S, Balogh Á, Papp Z, Brlecic P et al. Improvement of Left Ventricular Graft Function Using an Iron-Chelator-Supplemented Bretschneider Solution in a Canine Model of Orthotopic Heart Transplantation. Int J Mol Sci. 2022; 23 (13): 7453. https://doi.org/10.3390/ijms23137453.Szabó G, Loganathan S, Korkmaz-Icöz S, Balogh Á, Papp Z, Brlecic P et al. Improvement of Left Ventricular Graft Function Using an Iron-Chelator-Supplemented Bretschneider Solution in a Canine Model of Orthotopic Heart Transplantation. Int J Mol Sci. 2022; 23 (13): 7453. https://doi.org/10.3390/ijms23137453.Минасян СМ, Галагудза ММ, Дмитриев ЮВ, Карпов АА, Боброва ЕА, Красичков АС и др. Консервация донорского серд ца: история и современность с позиции трансляционной медицины. Регионарное кровообращение и микроциркуляция. 2014; 13 (3): 4–16. https://doi.org/10.24884/1682-6655-2014-13-3-4-16.Minasian SM, Galagudza MM, Dmitriev YuV, Karpov AA, Bobrova EA, Krasichkov AS et al. Donor heart preservation: history and current status in terms of translational medicine. Regional blood circulation and microcirculation. 2014; 13 (3): 4–16. (In Russ.). https://doi.org/10.24884/1682-6655-2014-13-3-4-16.Radakovic D, Karimli S, Penov K, Schade I, Hamouda K, Bening C et al. First clinical experience with the novel cold storage SherpaPakTM system for donor heart transportation. J Thorac Dis. 2020; 12 (12): 7227–7235. https://doi.org/10.21037/jtd-20-1827.Radakovic D, Karimli S, Penov K, Schade I, Hamouda K, Bening C et al. First clinical experience with the novel cold storage SherpaPakTM system for donor heart transportation. J Thorac Dis. 2020; 12 (12): 7227–7235. https://doi.org/10.21037/jtd-20-1827.Horch DF, Mehlitz T, Laurich O, Abel A, Reuter S, Pratschke H et al. Organ transport temperature box: Multicenter study on transport temperature of organs. Transplant Proc. 2002; 34 (6): 2320. https://doi.org/10.1016/s0041-1345(02)03253-0.Horch DF, Mehlitz T, Laurich O, Abel A, Reuter S, Pratschke H et al. Organ transport temperature box: Multicenter study on transport temperature of organs. Transplant Proc. 2002; 34 (6): 2320. https://doi.org/10.1016/s0041-1345(02)03253-0.Michel SG, LaMuraglia Ii GM, Madariaga ML, Anderson LM. Innovative cold storage of donor organs using the Paragonix Sherpa Pak TM devices. Heart Lung Vessel. 2015; 7 (3): 246–255.Michel SG, LaMuraglia Ii GM, Madariaga ML, Anderson LM. Innovative cold storage of donor organs using the Paragonix Sherpa Pak TM devices. Heart Lung Vessel. 2015; 7 (3): 246–255.Kothari P. Ex-Vivo Preservation of Heart Allografts – An Overview of the Current State. J Cardiovasc Dev Dis. 2023; 10 (3): 105. https://doi.org/10.3390/jcdd10030105.Kothari P. Ex-Vivo Preservation of Heart Allografts – An Overview of the Current State. J Cardiovasc Dev Dis. 2023; 10 (3): 105. https://doi.org/10.3390/jcdd10030105.Ardehali A, Esmailian F, Deng M, Soltesz E, Hsich E, Naka Y et al. Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial. Lancet. 2015; 385 (9987): 2577–2584. https://doi.org/10.1016/s0140-6736(15)60261-6.Ardehali A, Esmailian F, Deng M, Soltesz E, Hsich E, Naka Y et al. Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial. Lancet. 2015; 385 (9987): 2577–2584. https://doi.org/10.1016/s0140-6736(15)60261-6.Ragalie WS, Ardehali A. Current status of normothermic ex-vivo perfusion of cardiac allografts. Curr Opin Organ Transplant. 2020; 25 (3): 237–240. https://doi.org/10.1097/mot.0000000000000759.Ragalie WS, Ardehali A. Current status of normothermic ex-vivo perfusion of cardiac allografts. Curr Opin Organ Transplant. 2020; 25 (3): 237–240. https://doi.org/10.1097/mot.0000000000000759.Stamp NL, Shah A, Vincent V, Wright B, Wood C, Pavey W et al. Successful Heart Transplant after Ten Hours Out-of-body Time using the TransMedics Organ Care System. Heart Lung Circ. 2015; 24 (6): 611–613. https://doi.org/10.1016/j.hlc.2015.01.005.Stamp NL, Shah A, Vincent V, Wright B, Wood C, Pavey W et al. Successful Heart Transplant after Ten Hours Out-of-body Time using the TransMedics Organ Care System. Heart Lung Circ. 2015; 24 (6): 611–613. https://doi.org/10.1016/j.hlc.2015.01.005.Voigt JD, Leacche M, Copeland H, Wolfe SB, Pham SM, Shudo Y et al. Multicenter Registry Using Propensity Score Analysis to Compare a Novel Transport/Preservation System to Traditional Means on Postoperative Hospital Outcomes and Costs for Heart Transplant Patients. ASAIO J. 2023; 69 (4): 345–349. https://doi.org/10.1097/mat.0000000000001844.Voigt JD, Leacche M, Copeland H, Wolfe SB, Pham SM, Shudo Y et al. Multicenter Registry Using Propensity Score Analysis to Compare a Novel Transport/Preservation System to Traditional Means on Postoperative Hospital Outcomes and Costs for Heart Transplant Patients. ASAIO J. 2023; 69 (4): 345–349. https://doi.org/10.1097/mat.0000000000001844.

The authors declare that there are no conflicts of interest present.